CoChat

Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Glucagon is commonly used during gastrointestinal examinations for the temporary inhibition of gastroduodenal movements. Three preparations of glucagon are now clinically available: those prepared by extraction from the pancreas (GL-P), by chemical synthesis (GL-S), and by genetic recombination (GL-G). The aim of this study was examine the mechanism of the inhibitory effect of glucagon on gastrointestinal motility and the cause of its side effects by comparing three glucagon preparations. In four conscious dogs, gastrointestinal contractions were monitored by means of chronically implanted force transducers. Each glucagon preparation (GL-P [15 microg/kg], GL-S [5, 15, 45 microg/kg], GL-G [15 microg/kg]), scopolamine butylbromide (0.4 mg/ kg), or saline was administered intravenously 20 min after the termination of spontaneous phase III contractions, and blood samples were taken at 5- to 10-min intervals. Barium was administered into the stomach 10 min after the infusion of each drug. The arrival of a barium meal in the stomach immediately stimulated gastrointestinal contractions, and the barium meal was expelled into the duodenum and jejunum from the stomach. Intravenous injection of 15 microg GL-S first stimulated duodenal contractions that propagated to the jejunum, followed by strong inhibition of the barium-induced gastrointestinal contractions. This inhibitory effect of glucagon and the activity of the glucagon-induced duodenal contractions were dose-related. The inhibitory effects of GL-G and GL-S were stronger than that of GL-P. Blood glucose and plasma insulin concentrations were raised after intravenous injection of each glucagon preparation, but there was no difference among the three preparations and no dose relationship. The inhibitory effects of glucagon depend on the material purity and dose, and the inhibitory mechanism was independent of any effect on carbohydrate metabolism. Glucagon administration caused phase III-like contractions in the duodenum and jejunum, which may be responsible for the side effects of glucagon.

Overview

Integrity signals

Registry

Crossref · 10.1007/s005350050184

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Cited by

See all 38

Metadata

Authors
Mochiki, E., Suzuki, H., Takenoshita, S., Nagamachi, Y., Kuwano, H., Mizumoto, A., & Itoh, Z.
Affiliations
Gunma University (JP)
Venue
Journal of Gastroenterology
Published
1998-11-05
Volume
33
Issue
6
Pages
835-841
ISSN
  • 0944-1174 (ISSN-L)
  • 1435-5922
OpenAlex
W2038548962
Cited by
38
References
18
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 1 · 2014: 2
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glucagon, gastrointestinal motility, pancreatic glucagon, barium meal, duodenal contractions, jejunum, phase III contractions, adverse effects, blood glucose, plasma insulin, scopolamine
MeSH terms
Analysis of Variance, Animals, Blood Glucose, Digestive System, Dogs, Dose-Response Relationship, Drug, Drug Compounding, Gastrointestinal Agents, Gastrointestinal Motility, Glucagon, Injections, Intravenous, Insulin, Muscle Contraction, Radiography, Reference Values

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon. https://app.cochat.ai/papers/10.1007/s005350050184
The paper
Mochiki, E., Suzuki, H., Takenoshita, S., Nagamachi, Y., Kuwano, H., Mizumoto, A., & Itoh, Z. (1998). Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon. Journal of Gastroenterology. https://doi.org/10.1007/s005350050184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.